Siemens 2009 Annual Report Download - page 275


 Managing Board statements, Independent auditors’ report, Additional information
 Notes to Consolidated Financial Statements
(in millions of €, except where otherwise
stated and per share amounts)
ants seek indeterminate damages, Siemens may not be able to
predict what the eventual loss or range of loss related to such
matters will be. The final resolution of the matters discussed in
this paragraph could have a material effect on Siemens’ busi-
ness, results of operations and financial condition for any re-
porting period in which an adverse decision is rendered. How-
ever, Siemens does not currently expect its business, results of
operations and financial condition to be materially affected by
the additional legal matters not separately discussed in this
paragraph.
 ADDITIONAL DISCLOSURES
ON FINANCIAL INSTRUMENTS
The following table presents the carrying amounts of each
category of financial assets and liabilities:
The following table presents the fair values and carrying
amounts of financial assets and liabilities measured at cost or
amortized cost:
In April 2009, the Defense Criminal Investigative Service of the
U.S. Department of Defense conducted a search at the prem-
ises of Siemens Medical Solutions USA, Inc. in Malvern, Penn-
sylvania, in connection with an investigation relating to a
Siemens contract with the U.S. Department of Defense for the
provision of medical equipment.
In June 2009, the Vienna prosecutor searched the offices of an
employee of Siemens AG Austria in connection with alleged
overpricing by a subcontractor for an IT project with the Aus-
trian federal data center (“Bundesrechenzentrum”). The prose-
cutor informed Siemens that the company is being regarded as
a victim.
In June 2009, the Company and two of its subsidiaries volun-
tarily self-reported, among others, possible violations of U.S.
Export Administration Regulations to the responsible U.S. au-
thorities.
For certain legal proceedings information required under IAS
37, Provisions, Contingent Liabilities and Contingent Assets, is
not disclosed, if the Company concludes that the disclosure
can be expected to seriously prejudice the outcome of the liti-
gation.
In addition to the investigations and legal proceedings de-
scribed above, Siemens AG and its subsidiaries have been
named as defendants in various other legal actions and pro-
ceedings arising in connection with their activities as a global
diversified group. Some of these pending proceedings have
been previously disclosed. Some of the legal actions include
claims or potential claims for punitive damages or claims for
indeterminate amounts of damages. Siemens is from time to
time also involved in regulatory investigations beyond those
described above. Siemens is cooperating with the relevant au-
thorities in several jurisdictions and, where appropriate, con-
ducts internal investigations regarding potential wrongdoing
with the assistance of in-house and external counsel. Given
the number of legal actions and other proceedings to which
Siemens is subject, some may result in adverse decisions.
Siemens contests actions and proceedings when it considers it
appropriate. In view of the inherent difficulty of predicting the
outcome of such matters, particularly in cases in which claim-
B27T081_E
September ,
 
Financial assets:
Loans and receivables 24,119 25,138
Cash and cash equivalents 10,159 6,893
Derivatives designated in a hedge
accounting relationship 1,895 538
Financial assets held for trading 976 459
Available-for-sale financial assets 561 703
37,710 33,731
Financial liabilities:
Financial liabilities measured
at amortized cost 28,539 26,337
Financial liabilities held for trading 864 1,004
Derivatives designated in a hedge
accounting relationship 134 401
29,537 27,742
Einrückungen wie im
Deutschen gemacht